Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Debt Ratio (2016 - 2025)

Ironwood Pharmaceuticals' Debt Ratio history spans 12 years, with the latest figure at 1.47 for Q4 2025.

  • For Q4 2025, Debt Ratio rose 34.27% year-over-year to 1.47; the TTM value through Dec 2025 reached 1.47, up 34.27%, while the annual FY2025 figure was 1.47, 34.27% up from the prior year.
  • Debt Ratio for Q4 2025 was 1.47 at Ironwood Pharmaceuticals, roughly flat from 1.48 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.7 in Q2 2025 and bottomed at 0.1 in Q4 2021.
  • The 5-year median for Debt Ratio is 1.06 (2023), against an average of 0.91.
  • The largest annual shift saw Debt Ratio increased 2.64% in 2024 before it skyrocketed 58.61% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.1 in 2021, then increased by 7.33% to 0.11 in 2022, then soared by 852.8% to 1.06 in 2023, then grew by 3.46% to 1.1 in 2024, then skyrocketed by 34.27% to 1.47 in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Debt Ratio are 1.47 (Q4 2025), 1.48 (Q3 2025), and 1.7 (Q2 2025).